1. Drugs in Development for Hepatitis B

   • Altaf Dawood
   • Syed Abdul Basit
   • Robert G. Gish

   Leading Article Open access 28 June 2017 Pages: 1263 - 1280

   

2. Targeting the PGD₂/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives

   • Maciej Kupczyk
   • Piotr Kuna

   Leading Article Open access 13 June 2017 Pages: 1281 - 1294

   

3. Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal

   • Maurizio de Martino
   • Alberto Chiarugi
   • Gianluigi L. de’ Angelis

   Review Article Open access 09 June 2017 Pages: 1295 - 1311

4. Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies

   • Tessa G. Steenbruggen
   • Mette S. van Ramshorst
   • Gabe S. Sonke

   Review Article 14 June 2017 Pages: 1313 - 1336

   

5. Therapeutic Utility of Opioids for Restless Legs Syndrome

   • Susan E. Mackie
   • John W. Winkelman

   Review Article 14 June 2017 Pages: 1337 - 1344

6. Early Use of Ceftaroline Fosamil in the United States Veterans Health Care System

   • Rachel S. Britt
   • Kirk E. Evoy
   • Christopher R. Frei

   Original Research Article 29 June 2017 Pages: 1345 - 1351

7. Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes

   • Lesley J. Scott

   Adis Drug Evaluation 30 June 2017 Pages: 1353 - 1362

8. Abaloparatide: First Global Approval

   • Matt Shirley

   AdisInsight Report 17 June 2017 Pages: 1363 - 1368

   

9. Durvalumab: First Global Approval

   • Yahiya Y. Syed

   AdisInsight Report Open access 22 June 2017 Pages: 1369 - 1376